JAK/STAT 信号通路

选项
视图 列表 网格

7 项目

设置降序方向
  1. (3S,4S)-托法替尼
      规格或纯度 :
    • ≥96%
    CAS号 : 1092578-47-6        Compound CID : 20111936
    分子式: C16H20N6O        分子量: 312.37
    IUPAC Name: 3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
    SMILES: CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N
    InChIKey: UJLAWZDWDVHWOW-WCQYABFASA-N
    InChI: InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m0/s1
  2. (3S,4R)-托法替尼
      规格或纯度 :
    • ≥96%
    CAS号 : 1092578-48-7        Compound CID : 9966538
    分子式: C16H20N6O        分子量: 312.37
    IUPAC Name: 3-[(3S,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
    SMILES: CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N
    InChIKey: UJLAWZDWDVHWOW-DGCLKSJQSA-N
    InChI: InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13-/m1/s1
  3. AG 825,ErbB2抑制剂
      规格或纯度 :
    • ≥96%
    CAS号 : 149092-50-2        Compound CID : 6091659
    分子式: C19H15N3O3S2        分子量: 397.47
    IUPAC Name: (E)-3-[3-(1,3-benzothiazol-2-ylsulfanylmethyl)-4-hydroxy-5-methoxyphenyl]-2-cyanoprop-2-enamide
    SMILES: COC1=CC(=CC(=C1O)CSC2=NC3=CC=CC=C3S2)C=C(C#N)C(=O)N
    InChIKey: KXDONFLNGBQLTN-WUXMJOGZSA-N
    InChI: InChI=1S/C19H15N3O3S2/c1-25-15-8-11(6-12(9-20)18(21)24)7-13(17(15)23)10-26-19-22-14-4-2-3-5-16(14)27-19/h2-8,23H,10H2,1H3,(H2,21,24)/b12-6+
  4. Pertuzumab (anti-HER2)
      应用:
    • Animal Model
    • ELISA
    • Flow Cytometry
    • Functional Assay
    关联靶标: CYP1A2 ERBB2 ADRB2
    • 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
    • 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse)
    • 亚型: Human IgG1
    • 宿主种属: 人(Human)
    • 偶联: Unconjugated
    CAS号 : 380610-27-5        Compound CID : 5484725
    IUPAC Name: (2R,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol
    SMILES: CC1=C2CCCC2=C(C=C1)OCC(C(C)NC(C)C)O
    InChIKey: VFIDUCMKNJIJTO-BBRMVZONSA-N
    InChI: InChI=1S/C17H27NO2/c1-11(2)18-13(4)16(19)10-20-17-9-8-12(3)14-6-5-7-15(14)17/h8-9,11,13,16,18-19H,5-7,10H2,1-4H3/t13-,16-/m0/s1
  5. Cetuximab (anti-EGFR)
      应用:
    • Animal Model
    • ELISA
    • Flow Cytometry
    • Functional Assay
    关联靶标: EGFR
    • 简短描述: Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level< 0.01EU/μg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
    • 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
    • 亚型: Human IgG1
    • 宿主种属: 人(Human)
    • 偶联: Unconjugated
    CAS号 : 205923-56-4       
    分子式:        分子量: 145543.35
  6. Naquotinib(ASP8273)
    CAS号 : 1448232-80-1        Compound CID : 71667668
    分子式: C30H42N8O3        分子量: 562.71
    IUPAC Name: 6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide
    SMILES: CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC5CCN(C5)C(=O)C=C
    InChIKey: QKDCLUARMDUUKN-XMMPIXPASA-N
    InChI: InChI=1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1
每页